Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
644 | Advances in Neuroimmune Biology | journal | 0.153 Q4 | 10 | 0 | 6 | 0 | 3 | 6 | 0.50 | 0.00 | 0.00 | |
643 | Archaea | journal | 0.435 Q4 | 48 | 0 | 27 | 0 | 71 | 25 | 2.76 | 0.00 | 0.00 | |
642 | Autoimmunity Highlights | journal | 0.931 Q2 | 29 | 0 | 38 | 0 | 167 | 38 | 4.75 | 0.00 | 0.00 | |
641 | Biotechnology for Biofuels | journal | 1.022 Q1 | 129 | 0 | 725 | 0 | 5403 | 723 | 6.88 | 0.00 | 0.00 | |
640 | Biotekhnologiya | journal | 0.114 Q4 | 6 | 0 | 188 | 0 | 46 | 187 | 0.23 | 0.00 | 0.00 | |
639 | Current Immunology Reviews | journal | 0.283 Q4 | 23 | 0 | 30 | 0 | 50 | 28 | 0.10 | 0.00 | 0.00 | |
638 | Current Protocols in Immunology | journal | 2.340 Q1 | 57 | 0 | 47 | 0 | 218 | 47 | 3.67 | 0.00 | 0.00 | |
637 | Current Protocols in Microbiology | journal | 2.602 Q1 | 47 | 0 | 58 | 0 | 324 | 58 | 7.32 | 0.00 | 0.00 | |
636 | Frontiers in Clinical Drug Research - HIV | book series | 0.119 Q4 | 1 | 0 | 12 | 0 | 1 | 3 | 0.17 | 0.00 | 0.00 | |
635 | Human gene therapy methods | journal | 0.780 Q2 | 38 | 0 | 24 | 0 | 87 | 24 | 0.00 | 0.00 | 0.00 | |
634 | Immunology and Immunogenetics Insights | journal | 0.131 Q4 | 7 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
633 | Indian Journal of Biotechnology | journal | 0.142 Q4 | 43 | 0 | 92 | 0 | 39 | 92 | 0.16 | 0.00 | 0.00 | |
632 | Journal of Biotechnology: X | journal | 0.320 Q3 | 7 | 0 | 21 | 0 | 38 | 21 | 1.67 | 0.00 | 0.00 | |
631 | Karstenia | journal | 0.265 Q4 | 9 | 0 | 30 | 0 | 23 | 29 | 0.77 | 0.00 | 0.00 | |
630 | Korean Journal of Parasitology | journal | 0.463 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
629 | Microbiology Today | journal | 0.102 Q4 | 7 | 0 | 49 | 0 | 1 | 42 | 0.00 | 0.00 | 0.00 | |
628 | Multiple Sclerosis and Demyelinating Disorders | journal | 0.131 Q4 | 2 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
627 | NTP Immunotoxicity Technical Report Series | book series | 0.131 Q4 | 0 | 0 | 3 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
626 | Veterinary Parasitology: X | journal | 0.718 Q2 | 11 | 0 | 29 | 0 | 86 | 29 | 2.17 | 0.00 | 0.00 | |
625 | Virology: Research and Treatment | journal | 2.130 Q1 | 13 | 0 | 4 | 0 | 23 | 4 | 4.00 | 0.00 | 0.00 | |
624 | Access Microbiology | journal | 2 | 1 | 3 | 0 | 4 | 3 | 1.50 | 0.00 | 50.00 | ||
623 | Archiv fur Lebensmittelhygiene | journal | 0.120 Q4 | 18 | 1 | 16 | 23 | 10 | 16 | 0.00 | 23.00 | 52.94 | |
622 | Nigerian Journal of Parasitology | journal | 0.115 Q4 | 5 | 2 | 87 | 44 | 11 | 86 | 0.13 | 22.00 | 18.18 | |
621 | Oxford Open Immunology | journal | 2 | 2 | 1 | 35 | 5 | 1 | 5.00 | 17.50 | 27.27 | ||
620 | Cytokine: X | journal | 1.030 Q2 | 10 | 4 | 32 | 171 | 157 | 32 | 5.50 | 42.75 | 38.46 | |
619 | EcoSal Plus | journal | 1.828 Q1 | 41 | 4 | 41 | 383 | 228 | 41 | 5.36 | 95.75 | 40.00 | |
618 | Antiviral Chemistry and Chemotherapy | journal | 0.518 Q3 | 59 | 6 | 28 | 200 | 84 | 27 | 2.43 | 33.33 | 52.00 | |
617 | European Cytokine Network | journal | 0.557 Q3 | 70 | 6 | 53 | 319 | 168 | 53 | 3.00 | 53.17 | 50.00 | |
616 | ImmunoTargets and Therapy | journal | 1.681 Q1 | 25 | 6 | 60 | 555 | 457 | 59 | 7.28 | 92.50 | 44.44 | |
615 | Journal of Insect Biotechnology and Sericology | journal | 0.115 Q4 | 22 | 6 | 26 | 143 | 3 | 26 | 0.06 | 23.83 | 22.58 | |
614 | Exercise Immunology Review | journal | 1.659 Q1 | 63 | 7 | 23 | 0 | 190 | 23 | 8.50 | 0.00 | 43.75 | |
613 | Open AIDS Journal | journal | 0.201 Q4 | 22 | 7 | 38 | 196 | 28 | 35 | 0.79 | 28.00 | 51.22 | |
612 | Autoimmune Diseases | journal | 0.565 Q2 | 41 | 8 | 16 | 411 | 48 | 16 | 3.18 | 51.38 | 47.22 | |
611 | International Journal of Probiotics and Prebiotics | journal | 0.155 Q4 | 20 | 8 | 14 | 286 | 11 | 14 | 0.79 | 35.75 | 53.57 | |
610 | Italian Journal of Mycology | journal | 0.227 Q4 | 5 | 8 | 23 | 387 | 24 | 23 | 1.22 | 48.38 | 67.86 | |
609 | Mexican Journal of Biotechnology | journal | 0.167 Q4 | 7 | 8 | 53 | 319 | 33 | 53 | 0.64 | 39.88 | 41.18 | |
608 | Biotecnologia Aplicada | journal | 0.102 Q4 | 17 | 9 | 36 | 288 | 1 | 36 | 0.00 | 32.00 | 46.27 | |
607 | International Journal of Rheumatology | journal | 0.365 Q4 | 40 | 9 | 30 | 291 | 61 | 29 | 2.15 | 32.33 | 55.56 | |
606 | Current Cardiovascular Imaging Reports | journal | 0.299 Q3 | 25 | 10 | 82 | 456 | 85 | 82 | 1.00 | 45.60 | 47.50 | |
605 | Advances in Microbial Physiology | journal | 1.377 Q1 | 72 | 11 | 38 | 1435 | 200 | 22 | 3.90 | 130.45 | 0.00 | |
604 | Biotech Studies | journal | 4 | 11 | 22 | 540 | 23 | 22 | 1.05 | 49.09 | 45.83 | ||
603 | OBM Transplantation | journal | 0.181 Q4 | 5 | 11 | 113 | 519 | 41 | 106 | 0.30 | 47.18 | 50.94 | |
602 | Case Reports in Immunology | journal | 0.242 Q4 | 6 | 12 | 39 | 174 | 41 | 39 | 0.96 | 14.50 | 33.82 | |
601 | Comparative Parasitology | journal | 0.278 Q4 | 32 | 12 | 75 | 486 | 37 | 75 | 0.57 | 40.50 | 44.12 | |
600 | Current Trends in Immunology | journal | 0.120 Q4 | 9 | 12 | 39 | 650 | 8 | 39 | 0.19 | 54.17 | 66.67 | |
599 | Journal of Cellular Biotechnology | journal | 0.253 Q3 | 7 | 12 | 51 | 392 | 54 | 51 | 0.38 | 32.67 | 43.75 | |
598 | Asian Biotechnology and Development Review | journal | 0.122 Q4 | 11 | 13 | 28 | 279 | 7 | 23 | 0.29 | 21.46 | 55.56 | |
597 | European Journal of Microbiology and Immunology | journal | 0.614 Q3 | 15 | 13 | 56 | 657 | 229 | 56 | 2.31 | 50.54 | 34.04 | |
596 | Topics in antiviral medicine | journal | 0.778 Q3 | 46 | 13 | 45 | 330 | 110 | 42 | 0.87 | 25.38 | 38.24 | |
595 | Applied Microscopy | journal | 0.493 Q3 | 10 | 14 | 66 | 430 | 116 | 66 | 1.74 | 30.71 | 31.11 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®